Fiserv's weak results and guidance cut send stock plunging over 40%, prompting a leadership overhaul and a plan to restore growth and investor confidence.
Eagles acquire promising edge rusher Jaelan Phillips from Dolphins in exchange for 2026 third-round pick.
BridgeBio reports positive Phase 3 results for two late-stage candidates, encaleret and BBP-418, driving a sharp rally in the company's shares.
Fiserv's weak results and guidance cut send stock plunging over 40%, prompting a leadership overhaul and a plan to restore growth and investor confidence.
Eagles acquire promising edge rusher Jaelan Phillips from Dolphins in exchange for 2026 third-round pick.
BridgeBio reports positive Phase 3 results for two late-stage candidates, encaleret and BBP-418, driving a sharp rally in the company's shares.